Antisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide

29 Mar. 2022

Speaker: Annemieke Aartsma-Rus
Leiden University Medical Center, Netherlands;
Dutch Center for RNA Therapeutics (DCRT)

Recording

Slides